U.S. Markets close in 5 hrs 34 mins

OHR PHARMACEUTICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Ohr Pharmaceutical, Inc. - OHRP

NEW ORLEANS, Jan. 8, 2019 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Ohr Pharmaceutical, Inc. ("Ohr") (OHRP) with NeuBase Therapeutics, Inc. ("NeuBase") in a stock-for-stock transaction.  KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

Kahn Swick & Foti, LLC (

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit  https://www.ksfcounsel.com/cases/nasdaqcm-ohrp/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Kahn Swick & Foti, LLC
1100 Poydras St., Suite 3200
New Orleans, LA 70163

 

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/ohr-pharmaceutical-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick--foti-llc-investigates-merger-of-ohr-pharmaceutical-inc---ohrp-300774852.html